Skip to main content
. 2018 Nov 26;15(12):2646. doi: 10.3390/ijerph15122646

Table 2.

The incidence of cancer by GDM (gestational diabetes mellitus) and the results of survival analysis for cancer by GDM.

Variables GDM Unadjusted Adjusted ††
Yes No HR 95% CI p-Value HR 95% CI p-Value
Thyroid Cancer 131 (2.64%) 1822 (1.86%) 1.34 1.114–1.617 0.002 1.27 1.054–1.532 0.012 *
Gynecologic cancerother than ovary cancer 29 (0.58%) 388 (0.40%) 1.29 0.830–2.005 0.258 1.32 0.846–2.050 0.223
Ovary cancer 81 (1.63%) 1067 (1.09%) 1.28 0.938–1.738 0.12 1.23 0.901–1.673 0.193
Blood cancer 3 (0.06%) 30 (0.03%) 1.65 0.391–6.999 0.494 1.52 0.357–6.445 0.573
Gastric cancer 16 (0.32%) 234 (0.24%) 1.52 0.915–2.530 0.105 1.41 0.845–2.345 0.189
Hepatoma 21 (0.42%) 296 (0.30%) 1.57 0.986–2.509 0.057 1.5 0.939–2.397 0.09
Breast cancer 43 (0.87%) 646 (0.66%) 1.33 0.962–1.825 0.085 1.15 0.831–1.581 0.405
Colon cancer 20 (0.40%) 245 (0.25%) 1.45 0.874–2.411 0.1501 1.33 0.799–2.213 0.273
Total cancer 437 (8.79%) 6132 (6.26%) 1.39 1.261–1.531 <0.0001 1.31 1.192–1.449 <0.0001 *

Data are presented as n (%); †† Adjusted for maternal age, smoking, BMI before pregnancy and FBG. * Statistically significant, HR; hazard ratio.